期刊文献+

前列腺导管腺癌35例基底细胞变化的形态学 被引量:2

Morphological changes of base cells in 35 cases of prostatic duct adenocarcinomas
下载PDF
导出
摘要 目的:探讨前列腺导管腺癌(PDA)基底细胞的病变特点,为前列腺癌的病理诊断提供依据.方法:收集PDA标本35例,应用光镜、免疫组化EliVisionTMPlus二步法,选择34βE12,P63,P504S,PSA,PSAP抗体检测,观察PDA中基底细胞的缺失情况.结果:HE切片中35例PDA的基底细胞变化难以确定,但免疫组化显示13例PDA多数癌巢周围有较完整的基底细胞,3例PDA仅少数基底细胞残存,19例PDA基底细胞完全缺失;本组病例中27例PDA边缘少数小片状浸润癌和/或小腺泡癌成分中P504S阳性、34βE12、P63均阴性.结论:本研究发现35例PDA中的基底细胞尽管有明显缺失,但残存比率较高,提示在日益增多的前列腺穿刺标本中,基底细胞缺失并非是PDA诊断的最重要指标,若对基底细胞缺失期望值过高,则容易造成误诊或漏诊. AIM: To investigate the clinico-pathological features of basal cells in prostatic duct adenocarcinoma which can help pathological diagonosis of prostatic cancer. METHODS: Thirtyfive cases of prostatic duct adenocarcinoma were studied by hematoxylin and eosin staining and immunohistochemical techniques of two-step ElivisionTM Plus method to detect the expression of 34[3EI2, P63, P504S, PSA and PSAP. And the abscence of basal cells in prostatic duct adenocarcinoma was analysed according to the immunohistochemical staining. RESULTS: Of the total 35 cases, nearly intact basal cells were observed by immunohistochemical staining in 13 cases; only small amounts of incomplete basal cells in 3 cases; and complete absence of base cells in 19 cases 27 cases with P504S positive, 34βE12 and P63 negative staining at the edge of small invasive carcinoma and/or small acinous carcinoma around the prostatic duct adenocarcinoma were also observed. CONCLUSION : Although obvious absence of basal cells is usually observed in prostate duct adenocarcinoma, some basal cells still remain in the tumor tissues, which shows that the absence of basal cells is not the most significant index on the pathological diagnosis of prostate duct adenocarcinoma, and too much dependence on the importance of basal cell absence in diagnosis of prostate duct adenocarcinoma will lead to misdiagnosis and missed diagnosis.
出处 《第四军医大学学报》 北大核心 2008年第7期666-669,共4页 Journal of the Fourth Military Medical University
关键词 前列腺肿瘤 导管腺癌 基底细胞 免疫组化 prostatic neoplasms duct adenocarcinoma basal cell immunohistochemistry
  • 相关文献

参考文献5

二级参考文献35

  • 1景洪标,丁彦青,皋岚湘,丁华野,赵培冉.p63蛋白在乳腺良、恶性疾病鉴别诊断中的意义[J].诊断病理学杂志,2004,11(5):308-310. 被引量:10
  • 2孔祥田,邹万忠,夏同礼.4例前列腺疾病的病理诊断结果[J].诊断病理学杂志,1995,2(2):124-125. 被引量:2
  • 3Randolph T L,Mod Pathol,1997年,10卷,612页
  • 4Ro J Y,Hum Pathology,1990年,21卷,593页
  • 5Ro J Y,Am J Surg Pathol,1988年,12卷,453页
  • 6Tetu B,Cancer,1987年,59卷,1803页
  • 7Ribeiro-Silva A, Zamzelli Ramalho LN, Garcin SB, et al. Is p63 reliable in detecting microinvasion in ductal carcinoma in situ of the breast[J]. Pathol Oncol Res, 2003,9(1):20-23.
  • 8Reis-Filho JS, Schmitt FC. Taking advantage of basic research: P63 is a reliable myoepithelial and stem cell marker[J]. Adv Anat Pathol, 2002,9(5):280-289.
  • 9Signoretti S, Waltregny D, Dilks J, et al. p63 is a Prostate basal cell marker and is requieed for prostate development[J]. Am pathol, 2000,157(6):1769-1775.
  • 10Weir EG, Partin AW, Epstein JI. Correlation of serum prostate specific antigen and quantitative immunohistochemistry [J]. J Urol, 2000, 163(6):1739-1742.

共引文献46

同被引文献17

  • 1徐妙生,何艳姣,刘朝霞,李光.前列腺癌组织bcl-2、p53、P504S及34βE12蛋白的表达水平[J].首都医科大学学报,2007,28(4):538-541. 被引量:3
  • 2陈光勇,刘丽娜,周小鸽,张长淮,黄受方.α-甲酰基辅酶A消旋酶在前列腺腺癌诊断和鉴别诊断中的作用[J].中华病理学杂志,2004,33(5):419-423. 被引量:35
  • 3龚百生,阎洪涛,杨红,陈照祥.PCNA与CK34βE12在前列腺癌中表达的临床意义[J].现代泌尿外科杂志,2006,11(6):324-327. 被引量:4
  • 4埃布尔.泌尿系统及男性生殖器官肿瘤病理学和遗传学[M].冯晓莉,何群,陆敏,等译.北京:人民卫生出版社,2006:26.
  • 5Melicow MM,Pachter MR.Endometrial carcinoma of prostatic utricle(uterus masculinus)[J].Cancer, 1967,20( 10): 1715-1722.
  • 6Bostwick DG,Kindrachuk RW, Rouse RV.Prostatic adenocarcinoma with endomertrioid features.Clinilal,pathologic,and ultrastructural findings [J].Am J Surg Pathol,1985,9(8):595-609.
  • 7Stephens.Sternberg诊断外科病理学[M].3版.北京:北京大学医学出版社,2003:1929-1930.
  • 8Greene LF, Farrow GM,Ravits JM,et al.Prostatic adenocarcinoma of ductal origin[J]. J Urol, 1979,121 (3):303-305.
  • 9Christensen WN,Steinberg G,Walsh PC,et al.Prostatic duct adeno- carcinoma.Findings at radical prostatectomy[J].Cancer,1991,67(8): 2118-2124.
  • 10Kumar A,Mukherjee SD.Metastatic ductal carcinoma of the prostate: a rare variant responding to a common treatment[J].Can Urol Assoc J,2010,4(2):E50-E54.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部